Clinical Research Directory

Inclusion Criteria: * Signed and dated informed consent * Presbyopic adults, Male or female between 40-65 years of age who need from +1.25 D to +3.50 D of reading addition in the non- dominant eye to improve near visual acuity by at least one line or more. * Manifest refraction spherical equivalent (MRSE) between -0.75 and +1.50 D with ≤1.5 D of refractive cylinder in the non-dominant eye. * Stable refraction, i.e. MSRE within 0.50 D over prior 12 months in the non-dominant eye. * Corrected distance visual acuity CDVA ≥ 0.7 in the dominant and non-dominant eye Exclusion Criteria: * Anterior segment pathology in the non-dominant eye. * Signs or symptoms of clinically significant cataracts in the non-dominant eye. * Residual, recurrent, active ocular or uncontrolled eyelid disease, or any corneal abnormality (including endothelial dystrophy, recurrent corneal erosion, etc.) in the nondominant eye. * Visually significant macular pathology * Central corneal thickness \<470 microns in either eye and corneal curvature ≥ 50D * Corneal ectasia, keratoconus or form frust keratoconus * Clinically significant dry eye disease * Any prior ocular surgery in the non-dominant eye. * History of herpes zoster or herpes simplex keratitis in the non-dominant eye. * Inability of patient to understand the study procedures and thus inability to give informed consent. * Participation in another clinical study within the last 3 months * Already included once in this study (can only be included for one treated eye). * General history judged by the investigator to be incompatible with the study (e.g., life- * threatening patient condition, other condition where postoperative follow-up may be difficult). * known uncontrolled diabetes or other neuro-degenerative disorder (as corneal nerves can be affected leading to impaired wound healing)